148 related articles for article (PubMed ID: 31509346)
21. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States.
Rahman R; Schmaltz C; Jackson CS; Simoes EJ; Jackson-Thompson J; Ibdah JA
Cancer Med; 2015 Dec; 4(12):1863-70. PubMed ID: 26471963
[TBL] [Abstract][Full Text] [Related]
22. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
Chow WH; Shuch B; Linehan WM; Devesa SS
Cancer; 2013 Jan; 119(2):388-94. PubMed ID: 23147245
[TBL] [Abstract][Full Text] [Related]
23. Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis.
Callahan CL; Hofmann JN; Corley DA; Zhao WK; Shuch B; Chow WH; Purdue MP
Cancer Epidemiol; 2018 Oct; 56():31-37. PubMed ID: 30029068
[TBL] [Abstract][Full Text] [Related]
24. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
[TBL] [Abstract][Full Text] [Related]
25. An evaluation of race, ethnicity, age, and sex-based representation in phase I to II renal cell carcinoma clinical trials in the United States.
Kaldany A; Blum KA; Paulucci DJ; Beksac AT; Jayaratna I; Sfakianos JP; Badani KK
Urol Oncol; 2018 Aug; 36(8):363.e1-363.e6. PubMed ID: 29884343
[TBL] [Abstract][Full Text] [Related]
26. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
27. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
[TBL] [Abstract][Full Text] [Related]
28. Assessing the role of race in pathological upstaging of renal cell carcinoma: Results from the National Cancer Database.
Suss NR; Bruha MJ; Monaghan TF; Robins D; Flores V; Agudelo CW; Smith M; Hyacinthe L; McNeil BK; Weiss J; Winer A
Int J Clin Pract; 2021 Apr; 75(4):e13818. PubMed ID: 33159366
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
[TBL] [Abstract][Full Text] [Related]
30. Survival differences in nasopharyngeal carcinoma among racial and ethnic minority groups in the United States: A retrospective cohort study.
Challapalli SD; Simpson MC; Adjei Boakye E; Walker RJ; Antisdel JL; Ward GM; Osazuwa-Peters N
Clin Otolaryngol; 2019 Jan; 44(1):14-20. PubMed ID: 30216675
[TBL] [Abstract][Full Text] [Related]
31. Pathologic and clinical characteristics of early onset renal cell carcinoma.
Clemmensen T; Matoso A; Graham T; Lai WS; Rais-Bahrami S; Gordetsky J
Hum Pathol; 2018 Apr; 74():25-31. PubMed ID: 29133143
[TBL] [Abstract][Full Text] [Related]
32. Disparities in self-reported hypertension in Hispanic subgroups, non-Hispanic black and non-Hispanic white adults: the national health interview survey.
Borrell LN; Crawford ND
Ann Epidemiol; 2008 Oct; 18(10):803-12. PubMed ID: 18922396
[TBL] [Abstract][Full Text] [Related]
33. Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.
Paulucci DJ; Sfakianos JP; Skanderup AJ; Kan K; Tsao CK; Galsky MD; Hakimi AA; Badani KK
Oncotarget; 2017 Jan; 8(3):5196-5205. PubMed ID: 28029648
[TBL] [Abstract][Full Text] [Related]
34. The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.
Hofmann JN; Schwartz K; Chow WH; Ruterbusch JJ; Shuch BM; Karami S; Rothman N; Wacholder S; Graubard BI; Colt JS; Purdue MP
Cancer Causes Control; 2013 Jan; 24(1):167-74. PubMed ID: 23179659
[TBL] [Abstract][Full Text] [Related]
35. Factors related to lymph node sampling at the time of surgery in children, adolescents, and young adults with unilateral non-metastatic renal cell carcinoma.
Saltzman AF; Stokes W; Walker J; Cost NG
J Pediatr Urol; 2019 May; 15(3):259.e1-259.e7. PubMed ID: 30819622
[TBL] [Abstract][Full Text] [Related]
36. Associations of Renal Cell Carcinoma Subtype with Patient Demographics, Comorbidities, and Neighborhood Socioeconomic Status in the California Population.
Lichtensztajn DY; Hofer BM; Leppert JT; Brooks JD; Chung BI; Shah SA; DeRouen MC; Cheng I
Cancer Epidemiol Biomarkers Prev; 2023 Feb; 32(2):202-207. PubMed ID: 36480301
[TBL] [Abstract][Full Text] [Related]
37. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
38. Association of Race and Ethnicity With Late-Life Depression Severity, Symptom Burden, and Care.
Vyas CM; Donneyong M; Mischoulon D; Chang G; Gibson H; Cook NR; Manson JE; Reynolds CF; Okereke OI
JAMA Netw Open; 2020 Mar; 3(3):e201606. PubMed ID: 32215634
[TBL] [Abstract][Full Text] [Related]
39. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
40. A case-control study of occupation/industry and renal cell carcinoma risk.
Karami S; Colt JS; Schwartz K; Davis FG; Ruterbusch JJ; Munuo SS; Wacholder S; Stewart PA; Graubard BI; Rothman N; Chow WH; Purdue MP
BMC Cancer; 2012 Aug; 12():344. PubMed ID: 22873580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
